Psyence Biomedical (PBM) Other Working Capital Changes (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Other Working Capital Changes of $258092.0 in Q3 2025, up 2.5% quarter-over-quarter from $251796.0 in Q1 2025, and up 65.27% on a YoY basis from $156162.0 in Q3 2024.
Psyence Biomedical (PBM) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Psyence Biomedical's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $258092.0 for Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 65.27% year-over-year to $258092.0; the TTM figure through Sep 2025 stood at $258092.0 (up 65.27% YoY), while the FY2025 annual figure was $251796.0, down 21.83% from the prior year.
- Other Working Capital Changes was $258092.0 for Q3 2025 at Psyence Biomedical, up from $251796.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $322126.0 in Q1 2024 to a low of -$71665.0 in Q1 2023.
- Historically, Other Working Capital Changes has averaged $183302.2 across 3 years, with a median of $251796.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 549.49% in 2024, then fell 21.83% in 2025.
- A 3-year view of Other Working Capital Changes shows it stood at -$71665.0 in 2023, then jumped by 317.91% to $156162.0 in 2024, then surged by 65.27% to $258092.0 in 2025.
- The last three Other Working Capital Changes figures came in at $258092.0 (Q3 2025), $251796.0 (Q1 2025), and $156162.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 258,092.00 |
| Sep 30, 2025 | 258,092.00 |
| Mar 31, 2025 | 251,796.00 |
| Mar 31, 2025 | 251,796.00 |
| Sep 30, 2024 | 156,162.00 |
| Sep 30, 2024 | 156,162.00 |
| Mar 31, 2024 | 322,126.00 |
| Mar 31, 2024 | 322,126.00 |
| Mar 31, 2023 | -71,665.00 |
| Mar 31, 2023 | -71,665.00 |